Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Iron deficiency may contribute to hair loss.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.